P501: CLI120-001 PHASE1B DOSE ESCALATION STUDY OF RVU120 IN PATIENTS WITH AML OR HIGH RISK MDS SAFETY AND EFFICACY DATA UPDATE. (23rd June 2022) - Abboud, C.; Jan Maciej, Z.; Borthakur, G.; Solomon, S.; Howard, B.; Bradley, T.; Mouhayar, E.; Angelosanto, N.; Nogai, H.; Glasmacher, A.; Dudziak, R.; Brzozka, K.; et al.